NPS PHARMACEUTICALS INC — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c6700ca6-cd87-4244-8dac-96399027dbf1/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $5.0M | 2014-01-01 – 2014-12-31 | evidence 0001136261-15-000049 |
| FY 2013 | $-1.5M | 2013-01-01 – 2013-12-31 | evidence 0001136261-14-000082 |
| FY 2012 | $-1.1M | 2012-01-01 – 2012-12-31 | evidence 0001136261-13-000114 |
| FY 2011 | $545.0k | 2011-01-01 – 2011-12-31 | evidence 0001136261-12-000104 |
| FY 2010 | $9.6M | 2010-01-01 – 2010-12-31 | evidence 0001136261-12-000104 |
| FY 2009 | $27.7M | 2009-01-01 – 2009-12-31 | evidence 0001136261-12-000104 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).